| Bioactivity | c-ABL-IN-2 is a potent inhibitor of c-Abl. Activation of c-Abl has been implicated in various diseases, notably cancer. c-ABL-IN-2 has the potential for the research of neurodegenerative diseases (amyotrophic lateral sclerosis (ALS) and Parkinson’s disease (PD) and cancer (extracted from patent WO2020260871A1, compound 25)[1]. |
| Name | c-ABL-IN-2 |
| CAS | 2574593-54-5 |
| Formula | C21H20N4O |
| Molar Mass | 344.41 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Rebecca PAUL, et al. New compounds and methods. Patent WO2020260871A1. |
c-ABL-IN-2
CAS: 2574593-54-5 F: C21H20N4O W: 344.41
c-ABL-IN-2 is a potent inhibitor of c-Abl. Activation of c-Abl has been implicated in various diseases, notably cancer.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.